Maternal serum soluble HLA-G in complicated pregnancies

References

• Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1–22
   Google Scholar
• Hill LM. Oligohydramnios: sonographic diagnosis and clinical implications. Clin Obstet Gynecol 1997;40:314–27
   PubMedGoogle Scholar
• ACOG practice bulletin. Management of preterm labor. Number 43, May 2003. Int J Gynaecol Obstet 2003;82:127–35
   PubMed Web of Science ®Google Scholar
• ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2007;109:1007–19
   Google Scholar
• Maulik D. Fetal growth restriction: the etiology. Clin Obstet Gynecol 2006;49:228–35
   PubMed Web of Science ®Google Scholar
• Maulik D, Frances Evans J, Ragolia L. Fetal growth restriction: pathogenic mechanisms. Clin Obstet Gynecol 2006;49:219–27
   PubMed Web of Science ®Google Scholar
• Kim YM, Chaiworapongsa T, Gomez R, et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002;187:1137–42
   PubMed Web of Science ®Google Scholar
• Kim YM, Bujold E, Chaiworapongsa T, et al. Failure of physiologic transformation of the spiral arteries inpatients with preterm labor and intact membranes. Am J Obstet Gynecol 2003;189:1063–9
   PubMed Web of Science ®Google Scholar
• Le Bouteiller P, Mallet V. HLA-G and pregnancy. Rev Reprod 1997;2:7–13
   PubMedGoogle Scholar
• Ober C. HLA and pregnancy: the paradox of the fetal allograft. Am J Hum Genet 1998;62:1–5
   PubMed Web of Science ®Google Scholar
• Puppo F, Costa M, Contini P, et al. Determination of soluble HLA-G and HLA-A, -B, and –C molecules in pregnancy. Transplant Proc 1999;31:1841–3
   PubMedGoogle Scholar
• Hunt JS, Jadhav L, Chu W, et al. Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 2000;183:682–8
   PubMed Web of Science ®Google Scholar
• Roussev RG, Coulam CB. HLA-G and its role in implantation (review). J Assist Reprod Genet 2007;24:288–95
   Google Scholar
• Sargent IL. Does ‘soluble' HLA-G really exist? Another twist to the tale. Mol Hum Reprod 2005;11:695–8
   PubMedGoogle Scholar
• Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 2005;19:681–93
   PubMed Web of Science ®Google Scholar
• Roussev RG, Ng SC, Coulam CB. Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G. Am J Reprod Immunol 2007;57:262–9
   PubMed Web of Science ®Google Scholar
• Morales PJ, Pace JL, Platt JS, et al. Synthesis of beta(2)-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology 2007;122:179–88
   Google Scholar
• Le Bouteiller P. HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-boundand soluble protein. Int Immunol 1999;11:889–98
   Google Scholar
• O'Brien M, Dausset J, Carosella ED, Moreau P. Analysis of the role of HLA-G inpreeclampsia. Hum Immunol 2000;61:126–31
   Google Scholar
• Goldman-Wohl DS, Ariel I, Greenfield C, et al. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with preeclampsia. Mol Hum Reprod 2000;6:88–95
   PubMed Web of Science ®Google Scholar
• Van Lierop MJ, Wijnands F, Loke YW, et al. Detection of HLA-G by a specific sandwich ELISA using monoclonal antibodies G233 and 56B. Mol Hum Reprod 2002;8:776–84
   Google Scholar
• Redman CW. Immunology of preeclampsia. Semin Perinatol 1991;15:257–62
   PubMed Web of Science ®Google Scholar
• Hara N, Fujii T, Yamashita T, et al. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody “87G” and anti-cytokeratin antibody “CAM5.2”. Am J Reprod Immunol 1996;36:349–58
   PubMed Web of Science ®Google Scholar
• Yie SM, Li LH, Li YM, Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreasedin preeclampsia. Am J Obstet Gynecol 2004;191:525–9
   PubMed Web of Science ®Google Scholar
• Steinborn A, Varkonyi T, Scharf A, et al. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol 2007;57:277–86
   PubMed Web of Science ®Google Scholar
• Darmochwal-Kolarz D, Kolarz B, Rolinski J, et al. The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in preeclampsia. Folia Histochem Cytobiol 2012;50:286–91
   PubMed Web of Science ®Google Scholar
• Rizzo R, Andersen AS, Lassen MR, et al. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy. Am J Reprod Immunol 2009;62:320–38
   PubMed Web of Science ®Google Scholar
• Yie SM, Taylor RN, Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol 2005;193:204–8
   PubMed Web of Science ®Google Scholar
• Hackmon R, Koifman A, Hyodo H, et al. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am J Obstet Gynecol 2007;197:255.e1–5
   Google Scholar